CEO
Michael Bell
Employees
18,607
Industry
Research and Development in Biotechnology
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
October 03, 2023 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
September 26, 2023 | 9:44 pm
Portfolio Pulse from Benzinga Newsdesk
September 12, 2023 | 11:36 am
Portfolio Pulse from Happy Mohamed
August 10, 2023 | 2:53 pm
Portfolio Pulse from Happy Mohamed
August 04, 2023 | 11:13 am
Portfolio Pulse from Happy Mohamed
August 04, 2023 | 11:08 am
Portfolio Pulse from Benzinga Newsdesk
July 17, 2023 | 9:07 pm
Portfolio Pulse from Bill Haddad
June 26, 2023 | 11:37 am
Portfolio Pulse from Bill Haddad
June 26, 2023 | 11:35 am
Portfolio Pulse from Benzinga Newsdesk
May 26, 2023 | 7:13 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.